VIGL Vigil Neuroscience Inc
Price (delayed)
$1.77
Market cap
$82.61M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.07
Enterprise value
$55.61M
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is
Highlights
The debt has decreased by 7% YoY
Vigil Neuroscience's EPS has increased by 2.8% YoY
The quick ratio has dropped by 72% year-on-year and by 21% since the previous quarter
Vigil Neuroscience's equity has decreased by 38% YoY and by 19% from the previous quarter
Key stats
What are the main financial stats of VIGL
Market
Valuations
Earnings
Shares outstanding
46.67M
Market cap
$82.61M
Enterprise value
$55.61M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.01
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$89.68M
Net income
-$84.26M
EBIT
-$84.26M
EBITDA
-$82.4M
Free cash flow
-$51.23M
Per share
Balance sheet
Liquidity
EPS
-$2.07
EPS diluted
-$2.07
Free cash flow per share
-$1.26
Book value per share
$1.75
Revenue per share
$0
TBVPS
$2.89
Total assets
$117.69M
Total liabilities
$46.06M
Debt
$12.95M
Equity
$71.64M
Working capital
$66.44M
Debt to equity
0.18
Current ratio
2.95
Quick ratio
2.89
Net debt/EBITDA
0.33
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-69.8%
Return on equity
-96.5%
Return on invested capital
-122.6%
Return on capital employed
-100.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VIGL stock price
How has the Vigil Neuroscience stock price performed over time
Intraday
5.36%
1 week
-1.67%
1 month
-26.86%
1 year
-46.77%
YTD
4.12%
QTD
-0.56%
Financial performance
How have Vigil Neuroscience's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$89.68M
Net income
-$84.26M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 2% QoQ
Growth
What is Vigil Neuroscience's growth rate over time
Valuation
What is Vigil Neuroscience stock price valuation
P/E
N/A
P/B
1.01
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Vigil Neuroscience's EPS has increased by 2.8% YoY
Vigil Neuroscience's equity has decreased by 38% YoY and by 19% from the previous quarter
The stock's price to book (P/B) is 31% less than its last 4 quarters average of 1.4
Efficiency
How efficient is Vigil Neuroscience business performance
The return on equity has dropped by 68% year-on-year and by 15% since the previous quarter
The ROIC has plunged by 56% YoY and by 14% from the previous quarter
The return on assets has declined by 41% year-on-year and by 7% since the previous quarter
Dividends
What is VIGL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VIGL.
Financial health
How did Vigil Neuroscience financials performed over time
The total assets is 156% greater than the total liabilities
VIGL's total liabilities has surged by 87% year-on-year and by 8% since the previous quarter
The company's current ratio has shrunk by 72% YoY and by 21% QoQ
The debt is 82% less than the equity
Vigil Neuroscience's debt to equity has soared by 50% YoY and by 20% from the previous quarter
Vigil Neuroscience's equity has decreased by 38% YoY and by 19% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.